(Q45192925)

English

Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni

scientific article published in February 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

0 references

Schistosoma mansoni

0 references

hepatosplenomegaly

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

2

object named as

Mark Booth

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Birgitte J Vennervald

1

object named as

Birgitte J Vennervald

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

author name string

Anthony E Butterworth

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

H Curtis Kariuki

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Hilda Kadzo

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Edmund Ireri

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Clifford Amaganga

7

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Gachuhi Kimani

8

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Leecarol Kenty

9

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Joseph Mwatha

10

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

John H Ouma

11

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

150-160

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Ultrasonography in schistosomiasis in Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity twenty-three months after treatment with praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

The morbidity of schistosomiasis mansoni in Maniema (Zaire).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Assessing the public health importance of Schistosoma mansoni in different endemic areas: attributable fraction estimates as an approach.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Effect of antischistosomal chemotherapy on prevalence of Symmers' periportal fibrosis in Sudanese villages

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Lack of ultrasonographic evidence for severe hepatosplenic morbidity in schistosomiasis mansoni in Mali

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Measuring morbidity in schistosomiasis mansoni: relationship between image pattern, portal vein diameter and portal branch thickness in large-scale surveys using new WHO coding guidelines for ultrasound in schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Associations between anti-Schistosoma mansoni and anti-Plasmodium falciparum antibody responses and hepatosplenomegaly, in Kenyan schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Five year impact of chemotherapy on morbidity attributable to Schistosoma japonicum infection in the Dongting Lake region

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

The mechanism of malarial hepatomegaly and its relationship to hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Enlarged livers and spleens in an area endemic for malaria and schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.06.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TRSTMH.2004.06.009

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45192925&oldid=2069458488"